AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjerve, K. S.
Right arrow Articles by Alme, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjerve, K. S.
Right arrow Articles by Alme, K.
Agricola
Right arrow Articles by Bjerve, K. S.
Right arrow Articles by Alme, K.

American Journal of Clinical Nutrition, Vol 46, 570-576, Copyright © 1987 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Alpha-linolenic acid deficiency in man: effect of ethyl linolenate on plasma and erythrocyte fatty acid composition and biosynthesis of prostanoids

KS Bjerve, S Fischer and K Alme
Department of Clinical Chemistry, University Hospital, Trondheim, Norway.

Treatment of human alpha-linolenic acid deficiency (ALAD) with ethyl linolenate is reported. The patient's scaly dermatitis nearly disappeared after 5-d supplementation with 0.1 mL ethyl linolenate. Pretreatment content of various n-3 fatty acids in RBC was 0-15% of healthy controls. After 14 d of supplementation, cholesterol and triglycerides were reduced by 70% of pretreatment values, 22:5n-3 and 22:6n-3 increased three- to fourfold while 18:3n-3 and 20:5n-3 remained low, indicating a rapid elongation and desaturation of 18:3n-3 in ALAD. Urinary excretion of PGI2-M was approximately 10 times higher than in healthy control subjects, while PGI3-M excretion was low. Linolenate supplementation increased PGI2-M excretion twofold, while PGI3-M remained near detection limit. Platelet capacity to synthesize TXA2, and urinary excretion of TXB2+3-M were nearly unaffected by supplementation. The results confirm that the minimal daily requirement of alpha-linolenic acid is 0.2-0.3% of total energy.


This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
S. K Gebauer, T. L Psota, W. S Harris, and P. M Kris-Etherton
n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits
Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1526 - 1535S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
P. Grandjean and P. Weihe
Arachidonic acid status during pregnancy is associated with polychlorinated biphenyl exposure
Am. J. Clinical Nutrition, March 1, 2003; 77(3): 715 - 719.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
P. Grandjean, K. S Bjerve, P. Weihe, and U. Steuerwald
Birthweight in a fishing community: significance of essential fatty acids and marine food contaminants
Int. J. Epidemiol., December 1, 2001; 30(6): 1272 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. Grimsgaard, K. H. Bonaa, B. K. Jacobsen, and K. S. Bjerve
Plasma Saturated and Linoleic Fatty Acids Are Independently Associated With Blood Pressure
Hypertension, September 1, 1999; 34(3): 478 - 483.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by The American Society for Nutrition